Early steroid pulse therapy for children with suspected acute encephalopathy: An observational study

Yusuke Ishida1, Masahiro Nishiyama1, Hiroshi Yamaguchi1

  • 1Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.

Medicine
|August 16, 2021
PubMed

Insights

Early steroid pulse therapy did not improve outcomes for acute encephalopathy with elevated AST levels in children. However, prompt treatment may still help prevent neurological damage.

Area of Science:

  • Pediatric Neurology
  • Critical Care Medicine
  • Infectious Diseases

Background:

  • Steroid pulse therapy is a common treatment for virus-associated acute encephalopathy, particularly the cytokine storm subtype.
  • The effectiveness of early steroid pulse therapy for acute encephalopathy, especially with elevated aspartate aminotransferase (AST) levels, remains unclear.

Purpose of the Study:

  • To investigate the effectiveness of early steroid pulse therapy in children with suspected acute encephalopathy and elevated AST levels.
  • To analyze the relationship between the timing of steroid pulse therapy and patient prognosis.

Main Methods:

  • Retrospective study of children admitted between 2003 and 2017 with fever, convulsions, or impaired consciousness.
  • Inclusion criteria: refractory status epilepticus, prolonged neurological abnormality, or hemiplegia within 6 hours of onset, and AST >90 IU/L within 6 hours.
  • Comparison of prognosis (Pediatric Cerebral Performance Category Scale score 1-2) between groups receiving steroid pulse therapy within 24 hours and those who did not.

Main Results:

  • Thirteen of fifteen patients with acute encephalopathy received steroid pulse therapy within 24 hours; no significant difference in good prognosis was observed between groups.
  • No significant correlation was found between Pediatric Cerebral Performance Category Scale scores and the timing of steroid pulse therapy.
  • A trend towards better prognosis was observed with earlier administration of steroid pulse therapy, though not statistically significant.

Conclusions:

  • Early steroid pulse therapy within 24 hours did not improve the prognosis for children with suspected acute encephalopathy and elevated AST.
  • Earlier administration of steroid pulse therapy might potentially prevent neurological sequelae in these patients.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
55
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
98
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
49
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
44
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
75
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
46